In Vitro Fertilisation

Department of Health written question – answered on 5th April 2017.

Alert me about debates like this

Photo of Lord Alton of Liverpool Lord Alton of Liverpool Crossbench

To ask Her Majesty’s Government, with reference to paragraph 2.3 of the minutes of 9 March 2017 of the Licence Committee of the Human Fertilisation and Embryology Authority, which non-CE marked reagents will be used by Centre 0017 for the purposes of treatment involving pronuclear transfer between embryos to prevent transmission of serious mitochondrial disease; which laboratories will test the non-CE marked reagents for sterility and toxicity; and why non-CE marked reagents are being used.

Photo of Lord O'Shaughnessy Lord O'Shaughnessy The Parliamentary Under-Secretary of State for Health, Lord in Waiting (HM Household) (Whip)

The Human Fertilisation and Embryology Authority has advised that it is a condition of a licence that CE marked medical devices must be used wherever possible. In the case of pronuclear transfer, there are no appropriate CE marked reagents, meaning that for treatment to take place, non-CE marked reagents must be used. In this case, the centre must adhere to paragraph 26.5 in Guidance Note 26 of the Authority’s code of practice, which states that if a centre modifies a CE marked product or uses a product “off label”, it must complete a risk assessment and validation to ensure the product is safe. A copy of the Guidance Note 26 is attached.

Guidance Note 26 (PDF Document, 133.67 KB)

Does this answer the above question?

Yes0 people think so

No0 people think not

Would you like to ask a question like this yourself? Use our Freedom of Information site.